Skip to content
ReframedNewsLeft · Right · Centered
Today's StoriesArchiveAboutSign in
Today’s Stories›Technology & Society

China criticizes U.S. order requiring federal agencies to remove DeepSeek products

First covered Tuesday, October 20, 2026Technology & SocietyWell-covered

The Facts

The U.S. Department of Homeland Security ordered federal civilian agencies to remove DeepSeek products and services from their systems and barred future purchases, citing concerns that the Chinese AI company's technology could expose sensitive U.S. data to Beijing. China criticized the action as politicizing technology, sharpening a dispute over the security and governance of AI systems used by the U.S. government. Fox News

Context

What did the U.S. order require?

The Department of Homeland Security directed federal civilian agencies to remove DeepSeek products and services, including third-party technology developed using its AI models, and prohibited future purchases. Fox News

Why did U.S. officials cite security concerns?

The order said DeepSeek's AI models presented multiple threat vectors and raised concerns that Beijing could gain access to sensitive American data. Fox News

How did China respond?

China criticized the U.S. action and accused Washington of politicizing technology. Fox News

See this differently than someone you know would?

The receipts — 29 sources

Wire services (1)

ReutersYahoo NewsAstraZeneca partners with Oracle for AI-driven clinical tria...

Independent coverage (28)

조선일보Oracle, AstraZeneca Partner on AI-Driven Clinical Trial Pati...
TekediaAstraZeneca Partners With Oracle to Use AI in Clinical Trial...
BlockonomiOracle Corporation (ORCL) Stock: Rises as AstraZeneca AI Par...
firstwordpharma.comAstraZeneca seeks smarter trials, earlier care in AI tie-up ...
Yahoo! FinanceOracle (ORCL) Expands Its AI Healthcare Push With A New Drug...
TokenPostAstraZeneca and Oracle Plan AI Trial Recruitment Project in ...
EconoTimesAstraZeneca and Oracle Plan AI Trial Recruitment Program in ...
Analytics InsightAstraZeneca and Oracle Join Hands to Use AI in Clinical Tria...
Yahoo! FinanceAstraZeneca (LSE:AZN) Could Be 22% Undervalued On AI Partner...
NewsBytesAstraZeneca partners with Oracle to use AI in clinical trial...
StocktwitsOracle, AstraZeneca Explore AI To Tackle Clinical-Trial Recr...
The Next WebAstraZeneca and Oracle team up on AI to find patients for dr...
Investors HubAstraZeneca and Oracle Launch AI Partnership to Improve Clin...
London South EastAstraZeneca and Oracle partner to advance AI in clinical tri...
Fox NewsChina slams US ban on DeepSeek AI over security concerns
CryptopolitanOracle and AstraZeneca sign AI deal to speed up clinical tri...
CryptoPanicOracle and AstraZeneca sign AI deal to speed up clinical tri...
The Business StandardAstraZeneca partners with Oracle for AI-driven clinical tria...
@businesslineAstraZeneca partners with Oracle for AI-driven clinical tria...
Mirage NewsAstraZeneca, Oracle Launch Global AI Trial Collaboration
FierceBiotech - free daily biotech briefingAstraZeneca taps Oracle to help improve recruitment for clin...
FiercePharmaAstraZeneca taps Oracle to help improve recruitment for clin...
Investing.comStock Market News - Investing.com
The Wall Street JournalAstraZeneca Partners With Oracle to Refine Clinical Research...
MorningstarAstraZeneca Partners With Oracle to Refine Clinical Research...
RTTNewsAstraZeneca, Oracle Launch AI Collaboration To Optimise Clin...
Investing News NetworkOracle and AstraZeneca Partner to Advance AI-enabled Healthc...
Computer WeeklyAstraZeneca works with Oracle to speed up drug trials | Comp...

The news, read by both sides.

The day’s biggest stories in one short brief, built to show both sides and the competing values behind the headlines. Free in your inbox.

The news, read by both sides.

The day’s biggest stories in one short brief, built to show both sides and the competing values behind the headlines. Free in your inbox.

ReframedNews

The news, read by both sides.

A daily news briefing on the day’s top stories, built to show both sides.

Written by a machine, checked against the sources, read by people after it sends. Who writes this →

Navigate

Today’s StoriesArchiveSettings

Company

AboutSkylark CreationsSign InTerms of ServicePrivacy Policy

© 2026 Reframed.News

Made by Skylark Creations